Antilipemic Drugs
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
GEMFIBROZIL: products 1 to 6 of 6.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Gemfibrozil 300mg CapDIN 01979574 | General benefit | $0.1340per source unit | Requirements & sourcesBuild cost plan |
| Apo-Gemfibrozil 600mg TabDIN 01979582 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Lopid 300mg CapDIN 00599026 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Lopid 600mg TabDIN 00659606 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Teva-Gemfibrozil 300mg CapDIN 02241704 | General benefit | $0.1340per source unit | Requirements & sourcesBuild cost plan |
| Teva-Gemfibrozil 600mg TabDIN 02142074 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:00 CARDIOVASCULAR DRUGS.
24:06 Antilipemic Drugs.
24:06:24 PCSK9 Inhibitors.